文献速递心外重症与机械循环支持

美国左心室辅助装置植入的使用趋势、死亡率和资源利用

Trends in utilization, mortality, and resource use after implantation of left ventricular assist devices in the United States.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-02-19

该研究基于美国全国住院患者样本,分析2008至2016年成人左心室辅助装置植入的趋势。结果显示年植入量增长约3倍,院内死亡率从19.6%降至8.1%,低容量医院调整后死亡率较高但差异仅见于2008和2009年。

要点

  • 左心室辅助装置年植入量增长约3倍,院内死亡率从19.6%降至8.1%。
  • 低容量医院调整后死亡率较高,但差异仅2008和2009年显著。
  • 随技术成熟和经验积累,容量相关死亡率和资源利用差异已缩小。

核心结论

  • 美国左心室辅助装置使用快速增加,死亡率和发病率同步下降。
  • 随着技术成熟和经验积累,容量相关的死亡率和资源利用差异已缩小。

研究设计与样本

  • 回顾性队列研究,使用美国全国住院患者样本。
  • 纳入2008至2016年接受左心室辅助装置植入的成人患者。
  • 按年植入量将医院分为低、中、高容量机构,采用多因素logistic回归评估调整后死亡比值比。

主要发现

  • 研究期间估计23,972例患者接受左心室辅助装置植入,年植入量增长约3倍(趋势P<.001)。
  • 院内死亡率从2008年19.6%降至2016年8.1%(趋势P<.001)。
  • 低容量医院院内死亡率为12.0%,高容量医院为9.2%(P<.001)。
  • 低容量医院总体调整后死亡比值比为1.66(95%CI 1.28-2.15),但差异仅2008年(aOR 5.5,95%CI 1.9-15.8)和2009年(aOR 2.3,95%CI 1.4-3.8)显著。

临床怎么用

  • 左心室辅助装置植入量增长伴随死亡率下降,支持其应用推广。
  • 低容量医院的早期死亡风险较高,需关注经验积累期质量。
  • 近期容量相关结局差异缩小,但患者选择或医院质量的影响需进一步研究。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Adoption of implantable left ventricular assist devices has dramatically improved survival and quality of life in suitable patients with end-stage heart failure. In the era of value-based healthcare delivery, assessment of clinical outcomes and resource use associated with left ventricular assist devices is warranted. METHODS: Adult patients undergoing left ventricular assist device implantation from 2008 to 2016 were identified using the National Inpatient Sample. Hospitals were designated as low-volume, medium-volume, or high-volume institutions based on annual institutional left ventricular assist device case volume. Multivariable logistic regression was used to evaluate adjusted odds of mortality across left ventricular assist device volume tertiles. RESULTS: Over the study period, an estimated 23,972 patients underwent left ventricular assist device implantation with an approximately 3-fold increase in the number of annual left ventricular assist device implantations performed (P for trend <.001). In-hospital mortality in patients with left ventricular assist devices decreased from 19.6% in 2008 to 8.1% in 2016 (P for trend <.001) and was higher at low-volume institutions compared with high-volume institutions (12.0% vs 9.2%, P < .001). Although the overall adjusted mortality was higher at low-volume compared with high-volume institutions (adjusted odds ratio, 1.66; 95% confidence interval, 1.28-2.15), this discrepancy was only significant for 2008 and 2009 (low-volume 2008 adjusted odds ratio, 5.5; 95% confidence interval, 1.9-15.8; low-volume 2009 adjusted odds ratio, 2.3; 95% confidence interval, 1.4-3.8). CONCLUSIONS: Left ventricular assist device use has rapidly increased in the United States with a concomitant reduction in mortality and morbidity. With maturation of left ventricular assist device technology and increasing experience, volume-related variation in mortality and resource use has diminished. Whether the apparent uniformity in outcomes is related to patient selection or hospital quality deserves further investigation.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Sanaiha Y, Downey P, Lyons R, et al. Trends in utilization, mortality, and resource use after implantation of left ventricular assist devices in the United States. J Thorac Cardiovasc Surg. 2020. PMID: 32249087. doi:10.1016/j.jtcvs.2019.12.121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。